Institutional & Family Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-24
Closed -$1K 814
2021
Q4
$1K Sell
24
-1,000
-98% -$39.2K ﹤0.01% 738
2021
Q3
$49K Sell
1,024
-17
-2% -$787 0.01% 328
2021
Q2
$47K Hold
1,041
0.01% 335
2021
Q1
$50K Sell
1,041
-25
-2% -$1.3K 0.01% 355
2020
Q4
$57K Sell
1,066
-2
-0.2% -$90 0.01% 307
2020
Q3
$39K Hold
1,068
0.01% 315
2020
Q2
$33K Sell
1,068
-20
-2% -$554 0.01% 344
2020
Q1
$30K Buy
1,088
+1,000
+1,136% +$30K 0.01% 313
2019
Q4
$3K Hold
88
﹤0.01% 675
2019
Q3
$2K Buy
88
+1
+1% +$23 ﹤0.01% 709
2019
Q2
$2K Hold
87
﹤0.01% 725
2019
Q1
$2K Hold
87
﹤0.01% 728
2018
Q4
$1K Hold
87
﹤0.01% 779
2018
Q3
$1K Buy
+87
New +$1.2K ﹤0.01% 811

Other funds holding NEO

Institutional & Family Asset Management's NEO Position: Q1 2022 in Review

Institutional & Family Asset Management sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 24 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in NEO in Q3 2018 and held it in 14 quarters. The position peaked at $57K in Q4 2020. 280 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Institutional & Family Asset Management reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Institutional & Family Asset Management sold 24 NeoGenomics shares in Q1 2022, an estimated $1K.
  • Institutional & Family Asset Management first reported a position in NeoGenomics in Q3 2018 and held it in 14 quarters.
  • Institutional & Family Asset Management's NeoGenomics position peaked at $57K in Q4 2020.
  • 280 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Institutional & Family Asset Management's 13F filing for Q1 2022, filed 11 May 2022.